The Experience Matters. Let us show you why.
Contact us today.
Medical Marijuana and Drug Safety
Bart Cobert / May 07, 2019
Bart Cobert addresses the use of marijuana for medical purposes and the implications for Drug Safety.
Read More
Guide to Causality Assessment
Bart Cobert / Mar 20, 2019
What information should be examined in the study and work up of ADRs to determine whether the reaction is likely due to the drug or not.
Read More
UK and EMA Inspections Update 2019
Bart Cobert / Mar 05, 2019
Bart Cobert reviews the changes and updates happening with UK and EMA inspections.
Read More
Safety Reporting: Why We Do What We Do
Dr. Adele Mueller / Feb 07, 2019
We participate in safety reporting not only because it is required by law, but because we are HCPs whose first duty is always to protect the patient.
Read More
Brexit Update (again)
Bart Cobert / Jan 28, 2019
An update on the status of Brexit and the EMA move to Amsterdam.
Read More
Confusions in Drug Safety & Pharmacovigilance
Bart Cobert / Dec 27, 2018
Bart Cobert addresses confusing areas in Drug Safety and Pharmacovigilance including Brexit, basic terminology, date formatting and others.
Read More
Language and Translations in PV
Bart Cobert / Nov 27, 2018
Pharmacovigilance expert Bart Cobert examines the issues associated with language translation in PV and drug safety.
Read More
EMA and Brexit Yet Again: Part 3
Bart Cobert / Oct 02, 2018
Bart Cobert highlights the ongoing saga with EMA and Brexit. In this post, he elaborates on the lack of a current Brexit deal between the EU and the UK.
Read More
How are Empowered Nurses Changing the Pharma Industry?
Dr. Adele Mueller / Sep 13, 2018
Nurses today are in an optimal position to help pharma companies. Dr. Adele Mueller shares how empowering nurses empowers patients.
Read More
EMA and Brexit Yet Again: Part 2
Bart Cobert / Sep 05, 2018
Another update from Bart Cobert regarding the ongoing Brexit saga.
Read More
